Hill-Rom (NYSE: HRC), a leading medical technology company, announced its Welch Allyn unit's sponsorship of National Health Center Week and the National Association of Community Health Centers. The support exemplifies the company's dedication to providing industry leading diagnostic technologies to help community health centers build healthier communities....
HILL-ROM
READ MORE
|
Paladina Health, a direct primary care services company based in Denver, has acquired Indiana-based Activate Healthcare, a provider offering customized services to employers and unions for preventive and primary medical care. The collaboration creates one of the largest providers of value-based primary care across the U.S., serving more than 170,000 patients in 18 states. Financial terms of the deal were not disclosed....
HEALTHCARE FINANCE
READ MORE
|
If your weight is threatening your health and limiting your life, surgical weight loss options may be right for you....
MERCYHEALTH
READ MORE
|
The Federal Opposition will today make the first big ticket promise of the election campaign, vowing to unwind the controversial freeze on Medicare rebates the Government pays doctors for services......
ABC.NET.AU
READ MORE
|
MedPAC voted to approve a set of recommendations aimed at boosting the accuracy of Medicare Advantage encounter data. The recommendations will be included in the Medicare Payment Advisory Commission’s June report to Congress. The panel suggests a broader set of performance metrics, a payment withhold to push MA plans to comply and, if needed, mandate that noncompliant plans collect data through Medicare Administrative Contractors (MACs). The Centers for Medicare & Medicaid Services is ...
FIERCEHEALTHCARE
READ MORE
|
Flatiron Health’s chief medical officer is heading to the Food and Drug Administration, Forbes reports. CMO Amy Abernethy has been named as the agency’s principal deputy commissioner for food and drugs. Abernethy has been credited with helping Flatiron use EHR data for use in FDA drug approval. The company was purchased by Roche for $1.9 billion earlier this year. The appointment is the highest position at the FDA that isn’t politically appointed. Abernethy will oversee initiat...
FIERCEHEALTHCARE
READ MORE
|